BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8932374)

  • 21. Triple helix-forming oligonucleotides target psoralen adducts to specific chromosomal sequences in human cells.
    Oh DH; Hanawalt PC
    Nucleic Acids Res; 1999 Dec; 27(24):4734-42. PubMed ID: 10572173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides.
    Hélène C
    Anticancer Drug Des; 1991 Dec; 6(6):569-84. PubMed ID: 1772570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligonucleotide clamps arrest DNA synthesis on a single-stranded DNA target.
    Giovannangeli C; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10013-7. PubMed ID: 8234249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric recognition of psoralen interstrand crosslinks by the nucleotide excision repair and the error-prone repair pathways.
    Barre FX; Asseline U; Harel-Bellan A
    J Mol Biol; 1999 Mar; 286(5):1379-87. PubMed ID: 10064704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficient DNA repair of triple helix-directed double psoralen damage in human cells.
    Sandor Z; Bredberg A
    FEBS Lett; 1995 Oct; 374(2):287-91. PubMed ID: 7589555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-directed inhibition of DNA replication by triple helix formation.
    Diviacco S; Rapozzi V; Xodo L; Helene C; Quadrifoglio F; Giovannangeli C
    FASEB J; 2001 Dec; 15(14):2660-8. PubMed ID: 11726542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of triple-helix formation using a photo-cross-linkable aryl azide/biotin/oligonucleotide conjugate.
    Geselowitz DA; Neumann RD
    Bioconjug Chem; 1995; 6(4):502-6. PubMed ID: 7578371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen.
    Havre PA; Gunther EJ; Gasparro FP; Glazer PM
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7879-83. PubMed ID: 8356097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotor.
    Svinarchuk F; Debin A; Bertrand JR; Malvy C
    Nucleic Acids Res; 1996 Jan; 24(2):295-302. PubMed ID: 8628653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple helix directed psoralen adducts induce a low frequency of recombination in an SV40 shuttle vector.
    Sandor Z; Bredberg A
    Biochim Biophys Acta; 1995 Sep; 1263(3):235-40. PubMed ID: 7548210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of transcription elongation in the HER-2/neu coding sequence by triplex-directed covalent modification of the template strand.
    Ebbinghaus SW; Fortinberry H; Gamper HB
    Biochemistry; 1999 Jan; 38(2):619-28. PubMed ID: 9888801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence.
    Macaulay VM; Bates PJ; McLean MJ; Rowlands MG; Jenkins TC; Ashworth A; Neidle S
    FEBS Lett; 1995 Sep; 372(2-3):222-8. PubMed ID: 7556673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence-specific triple helix formation with genomic DNA.
    Ye Z; Guntaka RV; Mahato RI
    Biochemistry; 2007 Oct; 46(40):11240-52. PubMed ID: 17845009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenesis mediated by triple helix-forming oligonucleotides conjugated to psoralen: effects of linker arm length and sequence context.
    Raha M; Lacroix L; Glazer PM
    Photochem Photobiol; 1998 Mar; 67(3):289-94. PubMed ID: 9523530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trapping DNA polymerases using triplex-forming oligodeoxyribonucleotides.
    Samadashwily GM; Mirkin SM
    Gene; 1994 Nov; 149(1):127-36. PubMed ID: 7958976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine.
    Miller PS; Bi G; Kipp SA; Fok V; DeLong RK
    Nucleic Acids Res; 1996 Feb; 24(4):730-6. PubMed ID: 8604317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells.
    Degols G; Clarenc JP; Lebleu B; Léonetti JP
    J Biol Chem; 1994 Jun; 269(24):16933-7. PubMed ID: 8207016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple-helix formation by oligonucleotides containing the three bases thymine, cytosine, and guanine.
    Giovannangéli C; Rougée M; Garestier T; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8631-5. PubMed ID: 1528873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of interleukin-2 receptor alpha-subunit gene expression by oligonucleotide-directed triple helix formation.
    Grigoriev M; Praseuth D; Guieysse AL; Robin P; Thuong NT; Hélène C; Harel-Bellan A
    C R Acad Sci III; 1993; 316(5):492-5. PubMed ID: 8221232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of a triple-helix-specific cleaving reagent.
    Zain R; Marchand C; Sun J; Nguyen CH; Bisagni E; Garestier T; Hélène C
    Chem Biol; 1999 Nov; 6(11):771-7. PubMed ID: 10574778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.